Morning Overview on MSN
Psilocybin may break depression loops by reshaping brain wiring
Psilocybin, the psychoactive compound in so-called magic mushrooms, is emerging as one of the most intriguing tools in modern ...
Could psilocybin be on a trip to become a standard treatment for depression? Well, things are looking quite promising if you read the ‘shroom correctly. The latest evidence comes from a Phase 2 ...
Do you believe in magic? Studies that support the use of psychedelics to treat mental health problems are popping up like mushrooms. Yesterday, the Journal of the American Medical Association ...
3don MSN
Psilocybin shows greater potential than cannabinoids for obsessive-compulsive disorder treatment
In a review of previous studies, McMaster University researchers observe a stronger signal for psilocybin as a treatment for ...
ScienceAlert on MSN
Psilocybin Breaks Depressive Cycles by Rewiring The Brain, Study Suggests
Scientists have used a specially engineered virus to help track the brain changes caused by psilocybin in mice, revealing how ...
Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...
By combining psilocybin with a modified rabies virus that tracks neural connections, they mapped how networks change after a ...
An Arizona Army veteran who spent years in military service is now part of a pioneering effort led by one of the country’s most prominent psychedelic researchers.
Meta-analysis found that high-dose psilocybin was more effective than placebo in treating depressive symptoms in antidepressant trials, though its effect size was small compared to escitalopram. In a ...
An international collaboration led by Cornell researchers used a combination of psilocybin and the rabies virus to map ...
Psyence BioMed Announces Approval for Use of PsyLabs’ Psilocybin Product in Phase IIb Clinical Trial
The Phase IIb study will enroll approximately 87 participants and evaluate two therapeutic doses of psilocybin against a low-dose comparator, combined with structured psychotherapy. With multiple ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results